Align Technology 公告将于 9 月 15 日在 Baird 2026 全球医疗大会进行演讲（纯会议日程通知，无经营或财务增量信息）
全文为 IR 会议日程通知：只说明谁在何时何地演讲、如何看直播与回放，没有任何新增经营、财务、订单、指引、监管或资本配置事实，事件方向为 NEUTRAL，不存在可交易催化；因此不做多、不做空，也无需行情、KB、供应链或先例定价。若 9 月 15 日演讲中出现指引修正或新产品/订单披露，那是另一条独立事件，届时再研判。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
事实：Align Technology 于 2026-09-08（美股盘后）通过 Business Wire 及公司 IR 页面发布通知，CFO John Morici 与 IR 总监将于 2026-09-15 15:10–15:40 ET 在纽约 Baird 2026 全球医疗大会演讲，提供网络直播及约一个月回放；稿件其余内容为标准公司介绍（30.2 万医生客户、6 亿消费者机会、约 2350 万累计患者、29 年历史）与商标声明。影响链：会议出席本身不改变任何公司的收入、毛利、订单、指引、产能、监管地位或资本结构，市场对这类日程公告不做重定价；无二阶供应链传导，因为不存在品类、价格、份额或政策变量。价格/证据：一手源为公司 IR + Business Wire 通稿，可信度高但内容为零信息量；发布时点为美股收盘后（now=16:50 ET 盘后，不可连续成交），即便有信息也需等到下一交易日，且无信息可等。结论：event_direction=NEUTRAL，无正期望、无方向、无标的，判 AVOID（NO_EVENT），不生成 risk_signals（无新增净损害事实）。
先例如何影响了这次决策
对本次决策的影响:先例研究未启动，因为事件在 NO_EVENT 层即被判定为无可交易催化；即使补齐 12 条同类先例也不会改变'无方向、无增量'的结论
方向:无适用先例：会议出席通知不是价格事件，不存在可测的事件后收益分布
涨幅量级:不适用，未做幅度校准
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- fetch_decision_experience 成功 stock_tools HTTP · 11 ms
{
原文全文
展开原文 · 2,572 字
--(BUSINESS WIRE)--Sep. 8, 2026--
Align Technology, Inc.
(“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign
®
System of clear aligners, iTero™ intraoral scanners, and exocad™
CAD/CAM
software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at
http://investor.aligntech.com
. An archived replay will remain on the website for approximately one month.
Conference:
Baird 2026 Global Healthcare Conference
Date:
Tuesday, September 15, 2026
Presentation:
3:10 –
3:40 p.m. ET
Location:
New York, NY
Speakers:
John Morici
, EVP Global Finance and CFO
Madelyn Valente
, Director, Corporate Communications Investor Relations
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 302.0 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 23.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit
www.aligntech.com
for more information.
For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit
www.invisalign.com
. For additional information about the iTero digital scanning system, please visit
www.itero.com
. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit
www.exocad.com
.
Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20260908215434/en/
Align Technology
Madelyn Valente
(909) 833-5839
mvalente@aligntech.com
Zeno Group
Sarah Karlson
(828) 551-4201
sarah.karlson@zenogroup.com
Source: Align Technology, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。